JD Health International Inc
HKEX:6618
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
19.82
40.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one JD Health International Inc stock under the Base Case scenario is 34.59 HKD. Compared to the current market price of 28.6 HKD, JD Health International Inc is Undervalued by 17%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
JD Health International Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for JD Health International Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
JD Health International Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
JD Health International Inc. is not just another player in the rapidly evolving health and wellness landscape; it stands out as a pioneering force driven by technology and innovation. Established in 2015 as a subsidiary of JD.com, one of China's largest e-commerce platforms, JD Health is leveraging its parent company's robust logistics network and cutting-edge technology to reshape healthcare access in China. The company focuses on providing a seamless online healthcare experience, offering a diverse range of services that include online pharmacy sales, health consultations, and prescription management. With growing consumer demand for digital health solutions, JD Health is capitalizing on t...
JD Health International Inc. is not just another player in the rapidly evolving health and wellness landscape; it stands out as a pioneering force driven by technology and innovation. Established in 2015 as a subsidiary of JD.com, one of China's largest e-commerce platforms, JD Health is leveraging its parent company's robust logistics network and cutting-edge technology to reshape healthcare access in China. The company focuses on providing a seamless online healthcare experience, offering a diverse range of services that include online pharmacy sales, health consultations, and prescription management. With growing consumer demand for digital health solutions, JD Health is capitalizing on the shift toward telemedicine and remote healthcare services, positioning itself as a leader in this promising market.
For investors, JD Health International Inc. represents a compelling opportunity rooted in strong growth prospects and market leadership. As digital health continues to gain traction, the company has demonstrated impressive revenue growth, propelled by its extensive user base and innovative service offerings. JD Health’s commitment to leveraging advanced technologies like artificial intelligence and big data analytics not only enhances operational efficiency but also improves customer satisfaction and outcomes. Coupled with a solid financial backing from JD.com's established marketplace and logistics capabilities, JD Health is strategically poised to expand its footprint in both urban and rural areas, ultimately aiming to bridge the healthcare accessibility gap in China. As the company navigates the dynamic healthcare environment, its growth trajectory suggests a sustainable business model with substantial long-term value.
JD Health International Inc., a subsidiary of JD.com, focuses on the healthcare sector. Its core business segments can be categorized as follows:
-
Online Pharmaceutical and Health Products Retail: This segment involves the sale of prescription medications, over-the-counter drugs, health supplements, and other wellness products through JD Health's online platform. The company leverages JD.com’s extensive logistics network to ensure timely delivery of health products.
-
Healthcare Services: JD Health provides a range of healthcare services including online consultations with healthcare professionals, telemedicine, and health management services. This segment aims to enhance accessibility to healthcare and make medical advice more convenient for users.
-
Health Technology Solutions: This segment focuses on developing and offering technology-driven solutions for healthcare providers and patients. It includes tools for health monitoring, data analytics, and patient management systems that aim to enhance the overall efficiency and effectiveness of healthcare delivery.
-
Medical Devices and Equipment: JD Health also deals with the sale and distribution of medical devices and technological advancements in medical equipment. This segment caters to both individual consumers and healthcare institutions.
-
Health Data Insights: Leveraging the vast amount of health data generated through its services, JD Health aims to provide analytics and insights that can benefit healthcare providers, researchers, and policymakers.
These core segments position JD Health as a significant player in the growing digital healthcare landscape, particularly in China, where e-commerce and health technologies are increasingly integrated. The focus on a comprehensive healthcare ecosystem allows JD Health to cater to a wide range of consumer needs while promoting health and wellness.
JD Health International Inc., as a subsidiary of JD.com, holds several unique competitive advantages over its rivals in the health and wellness sector:
-
E-commerce Synergy: Leveraging JD.com's robust logistics and e-commerce infrastructure allows JD Health to offer efficient distribution, fast delivery, and a broad reach to a large customer base. This synergy enhances customer experience and satisfaction.
-
Data-Driven Insights: JD Health utilizes big data and artificial intelligence to analyze consumer behavior and preferences. This enables the company to offer personalized services, optimize inventory management, and improve marketing strategies.
-
Comprehensive Product Range: JD Health provides a wide array of health-related products and services, from pharmaceuticals to health management tools. This extensive product portfolio positions it as a one-stop-shop for consumers seeking health solutions.
-
Strong Partnerships: Collaborations with leading pharmaceutical companies, healthcare providers, and tech companies enhance JD Health’s product offerings and service capabilities. These partnerships can lead to innovative health solutions and improve service delivery.
-
Regulatory Compliance: Being part of a large, established company like JD.com provides JD Health with resources and expertise to navigate complex regulatory environments, ensuring compliance and enhancing trust with consumers.
-
Investment in Technology: Heavy investments in advanced technologies, such as telemedicine and digital health applications, enable JD Health to stay ahead of the curve and expand its service capabilities beyond traditional e-commerce.
-
Brand Trust and Recognition: JD.com has built a strong brand reputation in China. JD Health benefits from this recognition, instilling consumer trust which can be crucial in the healthcare sector.
-
Health Management Programs: JD Health’s focus on health management services, including chronic disease management and preventive care, distinguishes it from traditional pharmacies and e-commerce platforms that primarily focus on transactional sales.
By leveraging these unique competitive advantages, JD Health International Inc. positions itself favorably in the increasingly competitive health and wellness market.
JD Health International Inc, as a prominent player in the online healthcare sector, faces several risks and challenges moving forward:
-
Regulatory Compliance:
- Stringent regulations governing online healthcare services, data privacy (such as GDPR), and telemedicine could pose risks. Changes in policies could impact operational flexibility and increase compliance costs.
-
Intense Competition:
- The online healthcare market is highly competitive, with numerous players entering the space. JD Health faces competition from both traditional healthcare providers and other tech-driven health platforms.
-
Data Security and Privacy:
- With the handling of sensitive patient data, JD Health is susceptible to cybersecurity threats. Any data breach could lead to legal consequences and loss of customer trust.
-
Technological Disruptions:
- Rapid technological advancements require continuous investment in innovation. Falling behind in technology could diminish JD Health’s competitive edge.
-
Market Adoption:
- Consumer willingness to adopt online healthcare solutions can vary. Cultural differences and resistance from traditional healthcare practitioners could hinder market penetration.
-
Financial Performance Pressure:
- As a publicly traded company, JD Health is subject to the pressures of delivering consistent financial performance, which can be influenced by external economic conditions.
-
Supply Chain Vulnerabilities:
- Challenges in the supply chain, especially for medication and health products, can impact service delivery. Global disruptions (like pandemics) have shown how fragile supply chains can be.
-
Integration with Traditional Healthcare:
- Coordination with traditional healthcare systems and providers can be complex, limiting the effectiveness of services offered.
-
Consumer Trust and Reputation:
- Building and maintaining trust is critical in healthcare. Negative reviews or perceived service failures can significantly impact customer retention.
-
Global Expansion Risks:
- If pursuing international markets, JD Health may face geopolitical risks, differing regulatory environments, and the challenge of local competition.
-
Economic Downturns:
- Economic challenges can affect consumer spending on non-essential healthcare services, impacting revenue.
By strategically addressing these risks, JD Health can better position itself in the rapidly evolving healthcare landscape.
Revenue & Expenses Breakdown
JD Health International Inc
Balance Sheet Decomposition
JD Health International Inc
Current Assets | 56.5B |
Cash & Short-Term Investments | 49.9B |
Receivables | 829.1m |
Other Current Assets | 5.7B |
Non-Current Assets | 4.9B |
Long-Term Investments | 1.6B |
PP&E | 757.7m |
Intangibles | 2.3B |
Other Non-Current Assets | 267.6m |
Current Liabilities | 12.5B |
Accounts Payable | 8.3B |
Accrued Liabilities | 296.7m |
Other Current Liabilities | 3.9B |
Non-Current Liabilities | 154.5m |
Long-Term Debt | 132.6m |
Other Non-Current Liabilities | 21.9m |
Earnings Waterfall
JD Health International Inc
Revenue
|
54.8B
CNY
|
Cost of Revenue
|
-42.4B
CNY
|
Gross Profit
|
12.4B
CNY
|
Operating Expenses
|
-11B
CNY
|
Operating Income
|
1.4B
CNY
|
Other Expenses
|
1.2B
CNY
|
Net Income
|
2.6B
CNY
|
Free Cash Flow Analysis
JD Health International Inc
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
JD Health International Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
JD Health International Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
JD Health International Inc's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
JD Health International Inc's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
JD Health International Inc
According to Wall Street analysts, the average 1-year price target for JD Health International Inc is 34.27 HKD with a low forecast of 22.22 HKD and a high forecast of 44.74 HKD.
Dividends
Current shareholder yield for JD Health International Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-12-08. The firm mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The firm mainly conducts its businesses in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one JD Health International Inc stock under the Base Case scenario is 34.59 HKD.
Compared to the current market price of 28.6 HKD, JD Health International Inc is Undervalued by 17%.